A PSA blood test measures prostate-specific antigen in the blood. PSA is a protein made by cells of the prostate gland. It can be produced by normal prostate cells as well as prostate cancer cells. This is why PSA is useful, but also why it can be misunderstood.
A raised PSA does not automatically mean prostate cancer. The National Cancer Institute explains that both prostate cancer and benign conditions, especially benign prostatic hyperplasia and prostatitis, can cause PSA levels to rise.
This article explains what PSA is, why it may be tested, what can affect the result, and why PSA needs careful clinical interpretation.
What is PSA?
PSA stands for prostate-specific antigen. It is a protein produced by prostate gland cells. Small amounts of PSA can be found in the blood.
The prostate is a gland found in people assigned male at birth. It sits below the bladder and surrounds part of the urethra. PSA is linked with prostate tissue, which is why it can be used as a prostate-related blood marker.
The PSA test measures the amount of PSA in the blood. NCI states that PSA testing may be used to monitor prostate cancer progression, follow up prostate symptoms, or screen for prostate cancer in people without symptoms.
Why is PSA tested?
PSA may be tested for several reasons: follow-up of urinary or prostate symptoms, monitoring after prostate cancer treatment, screening discussions in selected people, follow-up of a previously raised PSA, risk assessment in people with higher prostate cancer risk, and monitoring known prostate disease.
Symptoms that may lead to PSA testing can include urinary changes, painful or frequent urination, blood in urine or semen, pelvic pain, or back pain. However, symptoms and PSA results need clinical interpretation. PSA is not a stand-alone answer.
PSA and screening
PSA screening is controversial because it can detect some prostate cancers early, but it can also lead to false positives, overdiagnosis, anxiety, unnecessary biopsies, and treatment of cancers that may never have caused harm.
NCI states that PSA testing is not recommended for routine prostate cancer screening in the general population and that many organisations advise people considering PSA screening to discuss risks and benefits with their doctors first. NCI also notes that some organisations recommend routine PSA testing from age 40 or 45 for people at higher risk, including Black men, people with inherited BRCA2 variants, and people with a father or brother who had prostate cancer.
The key message is that PSA is a useful but imperfect marker, and screening decisions depend on individual circumstances.
What is a normal PSA?
There is no single PSA number that perfectly separates normal from abnormal. NCI states that there is no single threshold that distinguishes a normal versus abnormal PSA result, partly because no specific PSA level means someone has prostate cancer. Higher PSA levels can increase the likelihood of prostate cancer being present, but they do not prove it.
Many sources historically discussed 4.0 ng/mL as a common threshold, but interpretation varies by age, medications, risk factors, prostate size, previous results, and clinical context. NCI notes that some doctors use higher cutoffs for older men and lower cutoffs for younger men.
This is why PSA should not be read as a simple pass/fail test.
What can raise PSA?
PSA can rise for reasons other than cancer. Possible causes include benign prostate enlargement, prostatitis or prostate inflammation, urinary infection, recent prostate biopsy, recent ejaculation, vigorous cycling or similar exercise, recent prostate examination or procedures, age-related prostate changes, prostate cancer, and laboratory and biological variation.
NCI states that prostate infection or inflammation, recent prostate biopsy, vigorous exercise such as cycling, and ejaculation can temporarily raise PSA. It also notes that people are often advised to wait until temporary factors resolve and avoid activities that may raise PSA for two days before testing.
Can medications lower PSA?
Yes. Some medications can lower PSA. NCI notes that drugs such as finasteride and dutasteride, used to treat benign prostatic hyperplasia, lower PSA levels.
This matters because a “lower” PSA result is not always straightforward if the person is taking medication that affects prostate tissue and PSA production.
What happens if PSA is raised?
A raised PSA may lead to repeat testing, observation, examination, imaging, urine or blood-based tests, or biopsy depending on the situation.
NCI explains that if a screening test shows an abnormal PSA in someone without symptoms, a doctor may recommend another PSA test in 6 to 8 weeks to confirm the finding. If PSA remains elevated, they may recommend continued observation, repeat PSA tests, digital rectal exams, or further testing such as MRI or other tests.
This repeat-testing approach shows why one PSA result is rarely the whole answer.
PSA after prostate cancer treatment
PSA can also be used after prostate cancer treatment. NCI explains that PSA is used after surgery or radiation therapy to monitor for recurrence. A rising PSA after treatment may be an early sign of recurrence, but a single elevated PSA does not always mean cancer has returned; doctors may repeat the test or look for a rising trend over time.
What sample is used?
PSA is measured using a blood sample, usually taken from a vein in the arm. The laboratory measures PSA concentration in serum or plasma depending on method and local practice. The result is usually reported in ng/mL, though units and reference comments vary by laboratory.
Why trend matters
PSA trend can be more useful than one isolated result. A stable PSA may mean something different from a PSA that is rising quickly. Previous results, age, prostate size, symptoms, infection history, and medications all help shape interpretation.
NCI notes that doctors may look for a trend of rising PSA over time rather than relying on a single elevated measurement.
Key takeaway
PSA is a prostate-related blood marker. It can be raised in prostate cancer, but also in benign enlargement, inflammation, infection, recent procedures, ejaculation, cycling, and other situations.
A raised PSA is not a diagnosis. It is a result that may need repeat testing, clinical review, risk assessment, imaging, or further investigation depending on context.
The best way to understand PSA is as a useful but imperfect prostate signal.
FAQ
Does a high PSA mean prostate cancer?
No. PSA can rise because of prostate cancer, but also because of benign enlargement, prostatitis, infection, exercise, ejaculation, or recent procedures.
What PSA level is abnormal?
There is no single threshold that perfectly separates normal from abnormal. NCI notes that 4.0 ng/mL is often considered abnormal, but cutoffs vary by age and context.
Why might PSA be repeated?
PSA can be temporarily raised. NCI says a repeat PSA after 6 to 8 weeks may be recommended to confirm an abnormal screening result.
Can medication affect PSA?
Yes. Medications such as finasteride and dutasteride can lower PSA levels.
Related tests and reading
- Tumour markers — PSA is one of several markers used in cancer monitoring. See: Tumour Markers Explained
- Full blood count — general health screening often ordered alongside PSA. See: Full Blood Count Explained
- Kidney function test — commonly checked as part of the same wellness panel. See: Kidney Function Test Explained
More questions answered
What does the PSA blood test actually measure?
The PSA blood test measures the concentration of prostate-specific antigen in the blood. The test is usually performed on serum or plasma, although the exact sample and method depend on the laboratory. The result is often interpreted alongside age, prostate examination and other clinically indicated investigations because one measurement rarely answers every clinical question. The practical takeaway is to read the value in the context of the laboratory report rather than treating it as a stand-alone diagnosis.
Do I need to fast before the PSA blood test?
Fasting is not automatically required just because this test has been requested. Preparation depends on the exact test request, so the laboratory or healthcare service should provide any fasting or timing instructions. If other tests are ordered at the same time, their preparation requirements may determine how the blood sample should be collected. The safest approach is to follow the collection instructions given for the specific appointment rather than fasting unnecessarily.
What can affect the PSA blood test result besides disease?
A PSA blood test result can be influenced by benign prostate enlargement, inflammation, recent prostate manipulation and prostate cancer. Some effects happen before analysis, which laboratories describe as pre-analytical factors, while others reflect genuine biological variation. The laboratory may also consider sample quality and analytical limitations before releasing a result. This is why an unexpected value may need context or repeat testing rather than an immediate conclusion.
Why might the PSA blood test be repeated?
A repeat test can help show whether a result is persistent, changing or likely to have been affected by a temporary factor. Comparing results over time creates a trend, which can be more informative than one isolated measurement. Repetition may also be needed when the sample was unsuitable or when the first result requires confirmation according to laboratory procedure. A healthcare professional decides whether repeat testing is clinically useful.
Why can the reference range for the PSA blood test differ between laboratories?
Laboratories may use different reference intervals because their analysers, reagents, calibration systems and reference populations are not always identical. Even when two laboratories measure the same analyte, differences in assay methods can produce different reporting ranges or units. The correct comparison is therefore the range printed on the same laboratory report as the result. A range found online should not replace the laboratory’s own interval.
How is the PSA blood test measured in the laboratory?
The sample is first checked to make sure it is suitable for testing, then the serum or plasma is processed according to the laboratory method. Measurement is typically performed using a validated immunoassay, with quality-control material used to check that the analytical system is behaving as expected. Results that trigger laboratory rules may be reviewed, repeated or investigated before release. This controlled quality process helps reduce avoidable analytical errors.
Can the PSA blood test diagnose a condition by itself?
No single PSA blood test result should usually be treated as a complete diagnosis on its own. The test can support prostate-related assessment without diagnosing cancer by itself, but the meaning depends on clinical context, other laboratory findings and sometimes imaging or examination. An abnormal value can have more than one explanation, while a value inside the reference interval does not exclude every condition. Personal interpretation should therefore be discussed with a healthcare professional.